Compare CRL & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRL | FRA |
|---|---|---|
| Founded | 1947 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 415.1M |
| IPO Year | 2000 | N/A |
| Metric | CRL | FRA |
|---|---|---|
| Price | $160.28 | $11.62 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $205.27 | N/A |
| AVG Volume (30 Days) | ★ 854.2K | 165.4K |
| Earning Date | 02-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,023,704,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.86 | $11.33 |
| 52 Week High | $228.88 | $13.10 |
| Indicator | CRL | FRA |
|---|---|---|
| Relative Strength Index (RSI) | 24.30 | 35.65 |
| Support Level | $148.34 | $11.60 |
| Resistance Level | $218.69 | $11.80 |
| Average True Range (ATR) | 9.40 | 0.10 |
| MACD | -6.28 | -0.01 |
| Stochastic Oscillator | 16.17 | 5.71 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.